CVS Caremark

Fierce Pharma

CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now

The owner of the U.S.’ largest pharmacy benefit manager won't cover Gilead Sciences’ long-acting HIV prevention drug Yeztugo, at least for now.

Fraiser Kansteiner Aug 21, 2025 3:02pm

Handshake for a pharmacy business deal

CalPERS swaps OptumRx for Caremark in risk-based PBM contract

Jul 15, 2025 4:52pm

A CVS pharmacy store on February 28 2025 in San Diego California

Caremark to pay $95M in Pennsylvania; CVS faces 3 new lawsuits

Jun 26, 2025 2:45am

Federal Trade Commission Commissioners Rebecca Kelly Slaughter L chats with Alvaro Bedoya R on Capitol Hill July 13

FTC firings spark legal uncertainty in PBM insulin case

Mar 21, 2025 6:30am

White Sticky Note With 2025 January Calendar And Red Push Pin On Blue Background

Payer Roundup—Setback in J&J case; Mental health parity lawsuit

Jan 31, 2025 3:00pm

A rolled up wad of hundred dollar bills with white pills spilling out

FTC: Big 3 PBMs generated $7.3B from specialty generic markups

Jan 14, 2025 12:25pm